Redcape LLC — Company Profile
Company overview
Redcape LLC, which does business as Redcape Investments, is a U.S. brokerage firm. Public sources describe it as an independent commodity-trading brokerage offering services to private and institutional investors. It is privately held; no public ticker, employee count, revenue band, or market capitalization could be verified from the sources reviewed. A CB Insights company record lists Redcape Investments but the headquarters location, year founded, and ownership were not retrievable in this search, and I could not confirm those details independently — they should be treated as unverified.
Products / services / operations
Based on the available description, Redcape Investments provides commodity trading and brokerage services, including access to managed commodity programs (CTAs) and algorithmic/automated trading. It presents itself as an independent brokerage, meaning it is not tied to a single clearing or execution counterparty. This is a small, service-oriented operating business rather than a manufacturer or technology vendor; no product line names were verifiable beyond the general categories above.
Patent-litigation posture
The structured case data show exactly one tracked matter, with Redcape appearing as a defendant and never as a plaintiff (0 plaintiff cases, 1 defendant case). That asymmetry is the classic profile of an operating company targeted in a third-party patent assertion, not an NPE. The suit, Chart Trading Development, LLC v. CQG, Inc. et al., was filed 2015-12-03 in the U.S. District Court for the Eastern District of Texas, Tyler Division — a venue historically favored by patent plaintiffs.
Notable cases or context
Redcape was one of roughly a dozen futures-industry defendants — alongside CQG, Rosenthal Collins Group, R.J. O'Brien, Crossland, Dorman Trading, The Price Futures Group, and Wedbush Futures — sued by Chart Trading Development, LLC over trading-interface patents (U.S. Patents 7,113,190; 8,380,611; 7,890,416; 8,041,626; and 8,060,435). Per Loeb & Loeb, which represented CQG and co-defendants including Redcape, the defendants jointly sought a stay and the patents were challenged in Covered Business Method reviews at the PTAB (CBM2016-00038 through -00048), with final written decisions issuing in 2017. No merits conclusions about Redcape are drawn here.